Huntington National Bank / BMY
Huntington National Bank’s Bristol-Myers Squibb Co Position
Does Huntington National Bank own Bristol-Myers Squibb Co (BMY)? Yes — 360.5K shares worth $22M (+0.12% of its 13F portfolio) as of Q1 2026, up from 133.3K shares the prior filed quarter.
Position Value
$22M
Q1 2026
Shares
360.5K
% of Portfolio
+0.12%
Quarters Held
30
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 360.5K | $22M | +0.12% |
| Q4 2025 | 133.3K | $7M | +0.04% |
| Q3 2025 | 139.2K | $6M | +0.04% |
| Q2 2025 | 153.8K | $7M | +0.05% |
| Q1 2025 | 158.8K | $10M | +0.07% |
| Q4 2024 | 164.5K | $9M | +0.07% |
| Q3 2024 | 164.5K | $9M | +0.06% |
| Q2 2024 | 166.2K | $7M | +0.05% |
| Q1 2024 | 180.9K | $10M | +0.08% |
| Q4 2023 | 203.3K | $10M | +0.09% |
| Q3 2023 | 218.3K | $13M | +0.13% |
| Q2 2023 | 230.0K | $15M | +0.14% |
| Q1 2023 | 228.2K | $16M | +0.16% |
| Q4 2022 | 247.7K | $18M | +0.19% |
| Q3 2022 | 253.1K | $18M | +0.21% |
| Q2 2022 | 258.7K | $20M | +0.21% |
| Q1 2022 | 262.1K | $19M | +0.18% |
| Q4 2021 | 268.0K | $17M | +0.15% |
| Q3 2021 | 279.3K | $17M | +0.17% |
| Q2 2021 | 284.7K | $19M | +0.19% |
| Q1 2021 | 262.5K | $17M | +0.20% |
| Q4 2020 | 271.2K | $17M | +0.22% |
| Q3 2020 | 280.0K | $17M | +0.25% |
| Q2 2020 | 287.7K | $17M | +0.27% |
| Q1 2020 | 305.4K | $17M | +0.32% |
| Q4 2019 | 317.8K | $20M | +0.31% |
| Q3 2019 | 314.9K | $16M | +0.26% |
| Q2 2019 | 335.2K | $15M | +0.24% |
| Q1 2019 | 366.7K | $17M | +0.29% |
| Q4 2018 | 388.5K | $20M | +0.36% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Huntington National Bank’s full portfolio or all institutional holders of BMY.